Skip to main content

Obstructive Sleep Apnoea Syndrome and Arrhythmia: Results of 10 Years’ Experience

  • Chapter
  • First Online:
The First Outstanding 50 Years of “Università Politecnica delle Marche”

Abstract

Obstructive sleep apnoea syndrome (OSAS) is a sleep-related breathing (SBD) disorder characterized by intermittent episodes of partial or complete obstruction of the upper airway, leading to cessation of breathing while asleep. OSAS elicits a series of mechanical, hemodynamic, chemical, neural, and inflammatory responses with adverse consequences on the cardiovascular system. Among these, cardiac arrhythmias are a common problem in affected patients, including both brady and tachy-arrhythmic manifestations. The strong association between OSAS and arrhythmia has prompted in last decades significant research aimed to understanding the mechanism connecting the two conditions, to define prevalence, to prospect new therapies and to explain the synergic negative effects in terms of morbidity and mortality in affected patients. In our center experience since 2009, we have focused our interest on atrial fibrillation (AF) and sleep apnea with the aim to define prevalence of SBD in a real-life population affected by AF and to assess the role of SBD on atrial remodelling, AF recurrence and therapies. Moreover, we have studied the complex relation between sleep apnoea and heart failure in patients treated with cardiac resynchronization therapy. We will report a revision of literature about sleep apnoea, AF and furthermore the main findings of our research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea. Am J Respir Crit Care Med 165(9):1217–1239

    Google Scholar 

  2. Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93

    Google Scholar 

  3. Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T et al (2007) Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49(5):565–571

    Google Scholar 

  4. Shepard JW, Garrison MW, Grither DA, Dolan GF (1985) Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 88(3):335–340

    Google Scholar 

  5. Fichter J, Bauer D, Arampatzis S, Fries R, Heisel A, Sybrecht GW (2002) Sleep-related breathing disorders are associated with ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. Chest 122:558–561

    Google Scholar 

  6. Leuenberger URS, Sweer L, Waravdekar N, Jacob E, Sweer L, Waravdekar N et al (1995) Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 79(2):581–588

    Google Scholar 

  7. Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96(4):1897–1904

    Google Scholar 

  8. Xie A, Skatrud JB, Puleo DS, Morgan BJ (2001) Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 91(4):1555–1562

    Google Scholar 

  9. Kanagala R (2003) Obstructive Sleep apnea and the recurrence of atrial fibrillation. Circulation 107(2):2589–2594

    Google Scholar 

  10. Ng CY (2011) Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 108(1):47–51

    Google Scholar 

  11. Pearse SG, Cowie MR, Nalliah CJ, Sanders P, Kalman JM, Chang C-C et al (2014) Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 62(4):300–305

    Google Scholar 

  12. Neilan TG, Farhad H, Dodson JA, Shah RV, Abbasi SA, Bakker JP et al (2013) Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc 2(6):e000421

    Google Scholar 

  13. Naruse Y, Tada H, Satoh M, Yanagihara M, Tsuneoka H, Hirata Y et al (2013) Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Hear Rhythm 10(3):331–337

    Google Scholar 

  14. Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC et al (2015) Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J 169(5):647–654

    Google Scholar 

  15. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL et al (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 173(8):910–916. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16424443

  16. Serizawa N, Yumino D, Kajimoto K, Tagawa Y, Takagi A, Shoda M et al (2008) Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter- defibrillator. Am J Cardiol 102(8):1064–1068

    Google Scholar 

  17. Voigt L, Haq SA, Mitre CA, Lombardo G, Kassotis J (2011) Effect of obstructive sleep apnea on QT dispersion: a potential mechanism of sudden cardiac death. Cardiology 118(1):68–73

    Google Scholar 

  18. Bitter T, Westerheide N, Prinz C, Hossain MS, Vogt J, Langer C et al (2011) CheyneStokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 32(1):61–74

    Google Scholar 

  19. Ryan CM, Usui K, Floras JS, Bradley TD (2005) Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 60(9):781–785

    Google Scholar 

  20. Mehra R, Stone KL, Varosy PD, Hoffman AR, Marcus GM, Blackwell T et al (2009) Nocturnal arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med 169(12):1147–1155

    Google Scholar 

  21. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J et al (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy-Devel. Europace

    Google Scholar 

  22. Bitter T, Langer C, Vogt J, Lange M, Horstkotte D, Oldenburg O (2009) Sleep disordered breathing in patients with atrial fibrillation and normal systolic left ventricular function. Dtsch Aerztebl Int 106(10):164–170

    Google Scholar 

  23. Braga B, Poyares D, Cintra F, Guilleminault C, Cirenza C, Horbach S et al (2009) Sleep-disordered breathing and chronic atrial fibrillation. Sleep Med 10(2):212–216

    Google Scholar 

  24. Mazza A, Bendini MG, Cristofori M, Nardi S, Leggio M, De Cristofaro R et al (2009) Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables. Europace 11(7):902–909. Available from: http://dx.doi.org/10.1093/europace/eup107

  25. Monahan K, Brewster J, Wang L, Parvez B, Goyal S, Roden DM et al (2012) Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol 110(3):369–372

    Google Scholar 

  26. Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Töpfer V (2007) Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9(3):251–257

    Google Scholar 

  27. Schulz R, Blau A, Börgel J, Duchna HW, Fietze I, Koper I et al (2007) Sleep apnoea in heart failure. Eur Respir J 29(6):1201–1205. Available from: http://erj.ersjournals.com/content/29/6/1201.abstract

  28. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O-A et al (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15(8):1070–1118. Available from: http://dx.doi.org/10.1093/europace/eut206

  29. Shalaby A, Atwood CW, Selzer F, Suffoletto M, Gorcsan J, Strollo P (2011) Cardiac resynchronization therapy and obstructive sleep-related breathing disorder in patients with congestive heart failure. Pacing Clin Electrophysiol 34(5):593–603

    Google Scholar 

  30. Lüthje L, Renner B, Kessels R, Vollmann D, Raupach T, Gerritse B et al (2009) Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnoea. Eur J Heart Fail 11(3):273–280

    Google Scholar 

  31. Simantirakis EN, Schiza SE, Siafakas NS, Vardas PE (2008) Sleep-disordered breathing in heart failure and the effect of cardiac resynchronization therapy. Europace 10(9):1029–1033

    Google Scholar 

  32. Gabor JY, Newman DA, Barnard-Roberts V, Korley V, Mangat I, Dorian P et al (2005) Improvement in Cheyne-Stokes respiration following cardiac resynchronisation therapy. Eur Respir J 26(1):95–100

    Google Scholar 

  33. Oldenburg O, Faber L, Vogt J, Dorszewski A, Szabados F, Horstkotte D et al (2007) Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail 9(8):820–826

    Google Scholar 

  34. Sredniawa B, Lenarczyk R, Kowalski O, Pruszkowska-Skrzep P, Kowalczyk J, Musialik-Lydka A et al (2009) Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy. Europace 11(1):106–114

    Google Scholar 

  35. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350(21):2140–2150. Available from: https://doi.org/10.1056/NEJMoa032423

  36. Mabo P, Victor F, Bazin P, Ahres S, Babuty D, Da Costa A et al (2012) A randomized trial of long- term remote monitoring of pacemaker recipients (The COMPAS trial). Eur Heart J 33(9):1105–1111. Available from: http://dx.doi.org/10.1093/eurheartj/ehr419

  37. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545

    Google Scholar 

  38. Rector TS, Kubo SH, Cohn JN (1993) Validity of the minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 71(12):1106–1107

    Google Scholar 

  39. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocard. J Am Soc Echocardiogr 18(12):1440–1463. Available from: https://doi.org/10.1016/j.echo.2005.10.005

  40. Iber C, Ancoli-Israel S, Chesson AL Jr., Quan SF for the American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st edn, Westchester, IL: American Academy of Sleep Medicine

    Google Scholar 

  41. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344(12):873–880

    Google Scholar 

  42. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352(15):1539–1549. Available from: https://doi.org/10.1056/NEJMoa050496

  43. Lamba J, Simpson CS, Redfearn DP, Michael KA, Fitzpatrick M, Baranchuk A (2011) Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace 13(8):1174–1179. Available from: http://dx.doi.org/10.1093/europace/eur128

  44. Anastasopoulos DL, Chalkias A, Iakovidou N, Xanthos T (2016) Effect of cardiac pacing on sleep-related breathing disorders: a systematic review. Heart Fail Rev 21(5):579–590

    Google Scholar 

  45. Stanchina ML, Ellison K, Malhotra A, Anderson M, Kirk M, Benser ME et al (2007) The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study. Chest 132(3):433–439

    Google Scholar 

  46. Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D et al (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial. Circulation 115(25):3173–3180

    Google Scholar 

  47. Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE et al (2010) Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 121(14):1598–1605

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laura Cipolletta .

Editor information

Editors and Affiliations

Appendix

Appendix

See Figs. 1, 2, 3, and 4.

Fig. 1
figure 1

Correlation between atrial dimension and apnoea severity index (a mean arterial saturation; b arterial saturation >90% of time in bed

Fig. 2
figure 2

Prevalence of SDB

Fig. 3
figure 3

The AHI value during follow up in patients with or without SDB

Fig. 4
figure 4

Example of cardiorespiratory monitoring at baseline and at 6 months in one patient

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cipolletta, L., Urbinati, A., Matassini, M.V., Francesca, M., Gasparini, S., Capucci, A. (2020). Obstructive Sleep Apnoea Syndrome and Arrhythmia: Results of 10 Years’ Experience. In: Longhi, S., et al. The First Outstanding 50 Years of “Università Politecnica delle Marche”. Springer, Cham. https://doi.org/10.1007/978-3-030-33832-9_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-33832-9_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-33831-2

  • Online ISBN: 978-3-030-33832-9

  • eBook Packages: EducationEducation (R0)

Publish with us

Policies and ethics